[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
Status:
Recruiting
Trial end date:
2025-06-15
Target enrollment:
Participant gender:
Summary
This will be a pivotal prospective prospective, international, multi-center, comparative,
randomized, cross-over, open-label lymphoma diagnostic trial to assess the diagnostic
performance and safety of the positron emission tomography (PET) imaging agent [68Ga]Ga-PTF)
, versus [18F]FDG PET/CT imaging, for staging of patients with confirmed marginal zone
lymphoma exemplary for CXCR4-positive malignant lymphomas.